Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
1(11%)
Results Posted
71%(5 trials)
Terminated
1(11%)

Phase Distribution

Ph not_applicable
1
11%
Ph phase_2
6
67%
Ph phase_1
2
22%

Phase Distribution

2

Early Stage

6

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
2(22.2%)
Phase 2Efficacy & side effects
6(66.7%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(7)
Terminated(1)

Detailed Status

Completed7
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
87.5%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (22.2%)
Phase 26 (66.7%)
N/A1 (11.1%)

Trials by Status

completed778%
terminated111%
recruiting111%

Recent Activity

1 active trials
Showing 5 of 9
completedphase_1

Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies

NCT01203722
recruitingphase_2

Allo HSCT Using RIC and PTCy for Hematological Diseases

NCT05805605
completedphase_2

Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant

NCT03961919
completedphase_2

Reduced Intensity Conditioning Transplant Using Haploidentical Donors

NCT02581007
completedphase_1

Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen

NCT00556452
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT01203722Phase 1

Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies

Completed
NCT05805605Phase 2

Allo HSCT Using RIC and PTCy for Hematological Diseases

Recruiting
NCT03961919Phase 2

Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant

Completed
NCT02581007Phase 2

Reduced Intensity Conditioning Transplant Using Haploidentical Donors

Completed
NCT00556452Phase 1

Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen

Completed
NCT01457885Phase 2

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

Completed
NCT01336712Phase 2

Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases

Completed
NCT00966498Not Applicable

Peripheral Blood Stem Cell Transplant (PBSCT) in Children With High Risk or Recurrent Solid Tumors

Terminated
NCT00186849Phase 2

Therapy for Children With Advanced Stage High Risk Neuroblastoma

Completed

All 9 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
9